优势眼葡萄膜黑色素瘤治疗致视力丧失后弱视眼视力改善
回顾性病例系列纳入21例成人弱视患者,其优势眼因葡萄膜黑色素瘤治疗而视力下降。治疗后弱视眼最佳矫正视力在11/21(52%;95%CI 30%至74%)患者中改善;在黑色素瘤眼视力降至弱视眼水平或更差的14例中,弱视眼视力改善9/14(64%;95%CI 35%至87%)。结论认为成人弱视眼视力可在对侧优势眼视力丧失后改善。
要点
- 成人弱视患者优势眼因葡萄膜黑色素瘤治疗视力下降后,弱视眼最佳矫正视力可改善。
- 21例中11例(52%;95%CI 30%至74%)弱视眼最佳矫正视力改善。
- 黑色素瘤眼视力降至弱视眼水平或更差的14例中9例(64%;95%CI 35%至87%)弱视眼改善。
核心结论
- 成人弱视眼视力可在对侧优势眼因葡萄膜黑色素瘤治疗而视力丧失后改善。
研究设计与样本
- 回顾性病例系列,纳入21例成人弱视且优势眼因葡萄膜黑色素瘤治疗而视力丧失的患者。
主要发现
- 初次就诊平均年龄56岁(范围39-73岁)。
- 葡萄膜黑色素瘤治疗后优势眼最佳矫正视力下降,弱视眼最佳矫正视力在11/21(52%;95%CI 30%至74%)患者中改善。
- 黑色素瘤眼视力降至弱视眼水平或更差者14例,其中弱视眼最佳矫正视力改善9/14(64%;95%CI 35%至87%)。
- 上述9例改善眼中,平均起始视力为logMAR 0.6(20/80),平均改善logMAR 0.4(4行±0.13,范围0.2-0.6)。
- 9例中8眼最终最佳矫正视力达20/25(n=3)或20/20(n=5)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the frequency and amount of visual improvement in amblyopic eyes of adults following visual loss in the dominant eye resulting from treatment of uveal melanoma. METHODS AND ANALYSIS: Retrospective case series of adult patients with amblyopia and dominant eye visual loss resulting from treatment of uveal melanoma. Review of best-corrected visual acuity (BCVA) in each eye (amblyopia eye vs melanoma eye) at date first seen and over time following treatment of uveal melanoma. BCVA in each eye was graded as improved (>2 logarithm of minimal angle of resolution (logMAR) lines) or unimproved (<2 logMAR lines). RESULTS: Twenty-one patients that met the inclusion criteria. Mean age at presentation was 56 years (range 39-73 years). Following treatment of the uveal melanoma and decline of BCVA in the dominant, the BCVA in the amblyopic eye improved in 11/21 (52%; 95% CI 30% to 74 %) patients. The degree of visual loss in the melanoma eye was to the level of the amblyopic eye or worse in 14 patients. In this group, BCVA improved in the amblyopic eye in 9/14 (64%; 95% CI 35% to 87 %) patients. Of these nine with improved eyes, the mean starting visual acuity was logMAR 0.6 (20/80) with mean improvement of logMAR 0.4 (4 lines±0.13 (range 0.2-0.6). Eight of nine eyes achieved a BCVA of 20/25 (n=3) or 20/20 (n=5). CONCLUSION: Visual acuity in the amblyopic eye of adults can improve following visual loss in the contralateral dominant eye associated with treatment for uveal melanoma.
引用
- Vagge A, Shields CL, Shields JA, et al. Visual improvement in amblyopic eye following treatment-induced vision loss in dominant eye with uveal melanoma. Br J Ophthalmol. 2019. PMID: 31097438. doi:10.1136/bjophthalmol-2018-313505
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。